Mary Ann Lansang

3.6k total citations
42 papers, 1.8k citations indexed

About

Mary Ann Lansang is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Mary Ann Lansang has authored 42 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 14 papers in Public Health, Environmental and Occupational Health and 13 papers in Epidemiology. Recurrent topics in Mary Ann Lansang's work include Mosquito-borne diseases and control (7 papers), Hepatitis B Virus Studies (6 papers) and Tuberculosis Research and Epidemiology (6 papers). Mary Ann Lansang is often cited by papers focused on Mosquito-borne diseases and control (7 papers), Hepatitis B Virus Studies (6 papers) and Tuberculosis Research and Epidemiology (6 papers). Mary Ann Lansang collaborates with scholars based in Philippines, Australia and Canada. Mary Ann Lansang's co-authors include Rodolfo Dennis, Marissa M. Alejandria, Leonila F. Dans, Jacinto Blas Mantaring, James L. Fisher, Daren K. Heyland, Lisa Cronin, Jean Carlet, Vincent M. Balanag and Cynthia A. Miguel and has published in prestigious journals such as PLoS ONE, Gut and American Journal of Epidemiology.

In The Last Decade

Mary Ann Lansang

37 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Ann Lansang Philippines 17 699 486 261 252 245 42 1.8k
Tim Baker Sweden 23 676 1.0× 418 0.9× 404 1.5× 146 0.6× 218 0.9× 85 2.0k
Helen McDonald United Kingdom 24 747 1.1× 407 0.8× 266 1.0× 240 1.0× 227 0.9× 84 2.1k
Sarah Kiguli Uganda 24 831 1.2× 725 1.5× 446 1.7× 276 1.1× 235 1.0× 124 2.7k
Leonila F. Dans Philippines 24 353 0.5× 406 0.8× 172 0.7× 605 2.4× 339 1.4× 88 2.5k
Enitan D. Carrol United Kingdom 30 1.5k 2.1× 514 1.1× 232 0.9× 506 2.0× 176 0.7× 125 2.7k
Felicity Fitzgerald United Kingdom 21 295 0.4× 345 0.7× 196 0.8× 221 0.9× 307 1.3× 104 1.4k
Peter Olupot‐Olupot Uganda 20 712 1.0× 509 1.0× 371 1.4× 317 1.3× 207 0.8× 111 2.3k
Robert N. Peck United States 30 584 0.8× 413 0.8× 422 1.6× 873 3.5× 199 0.8× 138 2.8k
Graeme Maguire Australia 33 908 1.3× 1.0k 2.1× 135 0.5× 811 3.2× 225 0.9× 126 3.1k
Daniel Ansong Ghana 28 330 0.5× 654 1.3× 263 1.0× 277 1.1× 187 0.8× 107 1.9k

Countries citing papers authored by Mary Ann Lansang

Since Specialization
Citations

This map shows the geographic impact of Mary Ann Lansang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ann Lansang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ann Lansang more than expected).

Fields of papers citing papers by Mary Ann Lansang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Ann Lansang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ann Lansang. The network helps show where Mary Ann Lansang may publish in the future.

Co-authorship network of co-authors of Mary Ann Lansang

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Ann Lansang. A scholar is included among the top collaborators of Mary Ann Lansang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Ann Lansang. Mary Ann Lansang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Dans, Leonila F., et al.. (2023). Durability and extent of protection of SARS-CoV-2 antibodies among patients with COVID-19 in Metro Manila, Philippines. Frontiers in Immunology. 14. 1190093–1190093. 2 indexed citations
4.
Lansang, Mary Ann, Marissa M. Alejandria, Irwin Law, et al.. (2021). High TB burden and low notification rates in the Philippines: The 2016 national TB prevalence survey. PLoS ONE. 16(6). e0252240–e0252240. 14 indexed citations
5.
Abad, Cybéle Lara R., et al.. (2021). Early experience with COVID-19 patients in a private tertiary hospital in the Philippines: Implications on surge capacity, healthcare systems response, and clinical care. Clinical Epidemiology and Global Health. 10. 100695–100695. 9 indexed citations
6.
Dans, Antonio L., Leonila F. Dans, Mary Ann Lansang, Maria Asuncion A. Silvestre, & Gordon Guyatt. (2018). Controversy and debate on dengue vaccine series—paper 3: final response to review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs. Journal of Clinical Epidemiology. 95. 142–142. 3 indexed citations
7.
Dans, Antonio L., Leonila F. Dans, Mary Ann Lansang, Maria Asuncion A. Silvestre, & Gordon Guyatt. (2017). Controversy and debate on dengue vaccine series—paper 1: review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs. Journal of Clinical Epidemiology. 95. 137–139. 38 indexed citations
8.
Lansang, Mary Ann, et al.. (2012). Response from the Global Fund. Bulletin of the World Health Organization. 90(1). 70–70. 3 indexed citations
9.
Liu, Qin, Katharine Abba, Marissa M. Alejandria, et al.. (2010). Cochrane review: Reminder systems and late patient tracers in the diagnosis and management of tuberculosis. Evidence-Based Child Health A Cochrane Review Journal. 5(3). 1206–1245. 1 indexed citations
10.
Liu, Qin, Katharine Abba, Marissa M. Alejandria, et al.. (2008). Reminder systems and late patient tracers in the diagnosis and management of tuberculosis. Cochrane Database of Systematic Reviews. CD006594–CD006594. 34 indexed citations
11.
Rudan, Igor, Mickey Chopra, Lydia Kapiriri, et al.. (2008). Setting Priorities in Global Child Health Research Investments: Universal Challenges and Conceptual Framework. Croatian Medical Journal. 49(3). 307–317. 83 indexed citations
12.
Arora, Narendra K., Antonio L Dans, & Mary Ann Lansang. (2007). INCLEN (The International Clinical Epidemiology Network) and the Journal of Clinical Epidemiology. Journal of Clinical Epidemiology. 60(6). 537–539.
13.
Pablos-Méndez, Ariel, et al.. (2005). Knowledge translation in global health.. PubMed. 83(10). 723–723. 37 indexed citations
14.
Alejandria, Marissa M., Mary Ann Lansang, Leonila F. Dans, & Jacinto Blas Mantaring. (2002). Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database of Systematic Reviews. CD001090–CD001090. 183 indexed citations
15.
Saul, Allan, et al.. (1997). Field epidemiological studies on malaria in a low endemic area in the Philippines. Acta Tropica. 63(4). 241–256. 29 indexed citations
16.
Lansang, Mary Ann, et al.. (1997). Risk factors for infection with malaria in a low endemic community in Bataan, the Philippines. Acta Tropica. 63(4). 257–265. 38 indexed citations
17.
Saul, Allan, et al.. (1997). Stability of malaria in a community in Bataan, The Philippines: prospects for control. Acta Tropica. 63(4). 267–273. 14 indexed citations
18.
Lansang, Mary Ann. (1996). Epidemiology and control of hepatitis B infection: a perspective from the Philippines, Asia.. Gut. 38(Suppl 2). S43–S47. 30 indexed citations
19.
Lansang, Mary Ann, et al.. (1989). Mother to child transmission of hepatitis B virus in the Philippines. Infection. 17(5). 275–279. 7 indexed citations
20.
Lansang, Mary Ann, et al.. (1989). A Cost-Effectiveness Analysis of a Simple Micromethod for Hepatitis B Screening in Hepatitis B Virus Control Programmes. International Journal of Epidemiology. 18(Supplement 2). S38–S43. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026